Why nuts are a smart food choice while taking GLP-1 medications
Glucagon-like peptide-1 (GLP-1) medications, like Ozempic and Wegovy, have transformed the way diabetes and weight are managed. First developed to…
November 2025.
And available everywhere you listen to podcasts: https://pod.link/thehealthyhandful

In response to the surge in popularity of GLP-1 medications, we’re re-releasing a popular episode of The Healthy Handful investigating the effects of almonds on appetite-regulating hormones, appetite ratings, and energy intake.
Published in the European Journal of Nutrition, the randomised controlled trial found that those who consumed almonds – as opposed to an energy-equivalent carbohydrate snack – reduced energy intake at a subsequent meal by as much as 300 kilojoules.
Our guest, Dr Sharayah Carter – then early-career researcher with the University of South Australia – led the research study.
Key take-outs:
Dr Sharayah Carter is now a lecturer and researcher in Human Biosciences/Nutrition and Dietetics at RMIT. With more than a decade of clinical practice experience as an Accredited Practising Dietitian, she brings a wealth of practical knowledge to her academic role.
She completed her PhD at the University of South Australia, investigating the effects of intermittent, compared to continuous, energy restriction in people with type 2 diabetes.
Sharayah is especially passionate about developing new ways of knowing in nutrition by using transdisciplinary methods that integrate science, culture, emotion and lived experience.

Optimizing GLP-1 therapies for obesity and diabetes management
Sign up to NutENews
Follow us on Instagram, Facebook and LinkedIn
Credits
Host: Belinda Neville
Contact us
Published November 25, 2025
Be sure to follow us for great recipes,
Nut inspirations and fun facts
For up to date information & the latest research articles